Finance

Barclays reiterates Overweight on BridgeBio Pharma stock at $157

Barclays reiterates Overweight on BridgeBio Pharma stock at $157

I
Investing.com
April 28, 2026·1 min read
GM
Finance

Barclays reiterates Overweight on BridgeBio Pharma stock at $157

Original article

Barclays reiterates Overweight on BridgeBio Pharma stock at $157

Published by Investing.com

Read full article